Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Shattuck Labs Inc STTK

Healthcare Biotechnology
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40... see more

Recent & Breaking News (NDAQ:STTK)

Shattuck Labs to Host Conference Call and Webcast Highlighting Data Presented at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire November 4, 2021

Shattuck Labs Announces Participation in Upcoming November Investor Conferences

GlobeNewswire November 3, 2021

Shattuck Labs Announces Changes to its Board of Directors

GlobeNewswire October 28, 2021

Shattuck Labs to Present Clinical Data on SL-172154 and SL-279252 and Preclinical Data on SL-9258 at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

GlobeNewswire October 1, 2021

Shattuck Labs Announces Participation in Upcoming September Conferences

GlobeNewswire September 1, 2021

Shattuck Labs Reports Second Quarter 2021 Financial Results and Upcoming Phase 1 Dose Escalation Data for SL-172154 and SL-279252

GlobeNewswire August 11, 2021

Shattuck Labs Announces Participation in the BTIG Biotechnology Conference

GlobeNewswire August 6, 2021

Shattuck Labs to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 11, 2021

GlobeNewswire August 4, 2021

Shattuck Labs Appoints Abhinav A. Shukla as Chief Technical Officer

GlobeNewswire June 1, 2021

Shattuck Labs Reports First Quarter 2021 Financial Results and Recent Business Highlights

GlobeNewswire May 10, 2021

Shattuck Labs Announces Participation in Upcoming May Conferences

GlobeNewswire April 30, 2021

Shattuck Labs Announces Participation in the 7th Annual Truist Securities Life Sciences Summit

GlobeNewswire April 28, 2021

Shattuck Labs Highlights Preclinical Data for SL-9258 (TIGIT-Fc-LIGHT) in an Acquired Resistance Model and Expanded Preclinical Data from the GADLEN(TM) Platform at AACR 2021

GlobeNewswire April 12, 2021

Shattuck Labs Announces Participation in Needham's 20th Annual Healthcare Conference

GlobeNewswire April 6, 2021

Shattuck Labs Announces Promotion of Andrew R. Neill to Chief Financial Officer

GlobeNewswire March 16, 2021

Shattuck Labs Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights

GlobeNewswire March 15, 2021

Shattuck Labs to Present Two Posters at the 2021 American Association for Cancer Research (AACR) Annual Meeting

GlobeNewswire March 11, 2021

Shattuck Labs Announces Participation in Upcoming March Investor Conferences

GlobeNewswire February 23, 2021

Shattuck Labs Announces Participation in Citi's 2021 Virtual Immuno-Oncology Day

GlobeNewswire February 12, 2021

Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference

GlobeNewswire January 7, 2021